What Allergy Partners does

Allergy Partners operates the largest single-specialty allergy, asthma, and immunology practice network in the United States, comprising 110+ clinics across 20 states staffed by approximately 150 board-certified allergists and immunologists. The company originated as a community practice in Asheville, North Carolina and has scaled over four decades into a national platform that supports more than 300,000 patients, combining local clinic delivery with centralized clinical protocols. Service lines span diagnostic testing (skin, blood, food allergy, patch, pulmonary function, Restech, and FeNO via coVita), allergen immunotherapy (subcutaneous allergy shots including cluster immunotherapy, sublingual drops for environmental and food allergens), food oral immunotherapy (Food OIT), Food Allergy Risk Reduction (FARR), biologics, and prescription/OTC medications.

Revenue is generated through standard fee-for-service clinical billing against insurance payors with self-pay options, anchored by recurring multi-year immunotherapy regimens and biologics administration that produce high patient retention. The go-to-market is direct-to-consumer through local clinics, supported by physician referrals and a 'Become an Allergy Partner' recruitment program that onboard independent allergists and practices into the network — effectively a roll-up growth model. Marketing operates through condition-focused content (blog, video center), organic social channels (LinkedIn, YouTube, Facebook, X), and local SEO across clinic markets. Operations are physician-led, with leadership transition completed in November 2025 when William A. McCann, M.D. succeeded David Brown, M.D. as CEO.

Name

Allergy Partners

Legal name

Allergy Partners

Website

https://allergypartners.com

Company type

Private

Founded year

1977

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Allergy Partners is the largest U.S. single-specialty allergy, asthma, and immunology practice network, operating 110+ clinics across 20 states with 150+ board-certified allergists serving more than 300,000 patients. It delivers diagnostics, allergen immunotherapy, food oral immunotherapy, biologics, and related specialty treatments billed through insurance.

Ownership category

akta.pro rank

Product category

Allergy and Asthma Specialty Care Services

NAICS

Offices of Physicians (except Mental Health Specialists) (621111), Medical and Diagnostic Laboratories (6215)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Medical Laboratories (8071)

akta.pro primary industry

Allergy & Immunology Clinics (HLAKAAAA)

akta.pro secondary industries

Pediatric Allergy & Immunology (HLAKAAAB), Asthma & Allergy-Related Pulmonary Care (HLAKANAD), Autoimmune & Allergy Diagnostics (HLAAALAK), Food Allergy Evaluation & Management (HLAKAAAD)

Keywords

• Allergy care services
• Asthma treatment
• Clinical immunology
• Allergy diagnostics
• Immunotherapy services

Headquarters

HQ city

Skyland

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Clinical Services Revenue: Revenue generated from patient consultations, diagnostic testing, and treatment procedures including allergy shots, biologics, food oral immunotherapy, and sublingual immunotherapy. Services billed through insurance and self-pay.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

Allergy Partners operates the nation's largest specialty network of allergy, asthma, and immunology clinics, providing diagnostic testing, personalized treatment plans, and immunotherapy services to patients. The company delivers care through 110+ clinics staffed by 150+ board-certified allergists and immunologists across 20 states, offering allergy shots, sublingual immunotherapy, biologics, food oral immunotherapy, and medication management billed through insurance and self-pay.

Product overview

Allergy Partners is a healthcare network providing comprehensive allergy and asthma care services across the United States. The company operates as a network of over 110 clinics in 20 states, offering a unified platform of diagnostic testing (Blood Testing, Food Allergy Testing, Patch Testing, Pulmonary Function Testing, Restech Testing, Skin Testing), treatment services (Allergy Shots/Immunotherapy including Cluster Immunotherapy, Biologics, Medications), and specialized immunotherapy programs (Food Oral Immunotherapy, Food Sublingual Immunotherapy, Environmental Sublingual Immunotherapy, Food Allergy Risk Reduction). Through partnerships, they also provide medical devices like the NObreath FeNO monitoring device. Additional patient-facing services include a Patient Portal for appointment scheduling and medical record access.

Differentiator

Problem solved

Functional benefit

Products and services

• Allergy Shots (Immunotherapy) Subcutaneous immunotherapy (SCIT) treatment that gradually introduces allergens to dampen allergic responses, providing lasting relief for allergies and asthma; offered to patients in network clinics.
• Cluster Immunotherapy Accelerated build-up phase of immunotherapy consisting of nine weekly sessions where patients receive 1-3 doses every 30 minutes, enabling faster achievement of maintenance dosages.
• Biologics Advanced biologic treatments for allergies and asthma management offered to patients at network clinics.
• Medications Prescription and over-the-counter medications prescribed by network physicians for allergy and asthma symptom management.
• Food Oral Immunotherapy (Food OIT) Treatment program that builds tolerance to specific food allergens through gradual introduction of the allergen under medical supervision.
• Food Sublingual Immunotherapy (Food SLIT) Sublingual immunotherapy drops placed under the tongue to build tolerance to food allergens.
• Environmental Sublingual Immunotherapy (Environmental SLIT) Sublingual immunotherapy drops for environmental allergens such as pollen, pet dander, and dust mites.
• Food Allergy Risk Reduction (FARR) Program designed to reduce the risk of developing food allergies, particularly in pediatric patients.
• Blood Testing Laboratory blood tests performed in network clinics to identify specific allergen sensitivities.
• Food Allergy Testing Testing services specifically designed to identify food allergies and sensitivities in patients.
• Patch Testing Dermatological patch testing to identify contact allergens causing skin reactions.
• Pulmonary Function Testing Lung function tests performed in clinics to assess asthma severity and respiratory health.
• Restech Testing Advanced in-office testing for laryngopharyngeal reflux and related conditions.
• Skin Testing In-office skin testing where small amounts of allergens are applied to the skin to identify allergic reactions.
• NObreath FeNO Monitoring Device Non-invasive fractional exhaled nitric oxide (FeNO) device used for asthma diagnosis and management, provided across Allergy Partners clinics through collaboration with coVita.

Quantifiable outcome

• Largest allergy and asthma network in the U.S.
• +1 more outcomes

Named customers2 records

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

One partnership is on record.

• coVitacoreTechnology or Integration · 19 November 2025coVita and Allergy Partners collaborated to provide the NObreath FeNO monitoring device in the United States. This expansion allows Allergy Partners' over 110 clinics across 20 states to utilize non-invasive airway inflammation testing for improved asthma diagnosis and management.

Scale indicators5 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• HCA Healthcare: Large U.S. hospital and specialty care operator with affiliated physician networks that include allergy/immunology providers. Comparable as a healthcare delivery incumbent competing for physician talent, outpatient referrals, and payer contracts.
• DaVita: Specialty care network operator (originally dialysis-focused) that has built a model of physician-led, clinic-based specialty services at national scale. Comparable as a publicly-traded specialty healthcare platform demonstrating the scale and rollup playbook relevant to Allergy Partners.
• CVS Health (Oak Street Health, MinuteClinic): Retail health and primary care platform increasingly delivering basic allergy and asthma services through MinuteClinic and Oak Street Health. Functions as a broad incumbent whose primary care footprint could substitute for low-acuity allergy visits that currently funnel to specialty clinics.
• Optum (UnitedHealth Group): Vertically integrated care delivery and physician services arm of UnitedHealth Group, which has aggressively acquired specialty and primary care practices. Operates as a broader incumbent that overlaps with Allergy Partners' specialty clinic strategy and represents both a potential acquirer and competitive threat.

Direct peers

• Family Allergy & Asthma: Large multi-state allergy, asthma, and immunology specialty practice network operating across the Midwest and South. Direct competitor to Allergy Partners with a comparable model of affiliated clinics, board-certified allergists, and immunotherapy/biologics service offerings.
• Aspire Allergy & Sinus: Texas-headquartered allergy and sinus specialty practice chain with a strong focus on sublingual immunotherapy (SLIT) drops and clinic-based treatment programs. Comparable to Allergy Partners in service mix and patient acquisition model, with a regional footprint that overlaps in some markets.
• US Allergy & Sinus Centers: Multi-location allergy and sinus specialty clinic group offering testing, immunotherapy, and biologics in the U.S. Comparable specialty-practice business model targeting the same patient population with similar treatment modalities.

Others

• coVita: Medical device partner supplying the NObreath FeNO monitoring technology deployed across Allergy Partners' clinic network. Adjacent technology and supplier relationship supporting Allergy Partners' diagnostic capabilities in asthma management.
• Adherium: Digital respiratory health company whose Hailie Smartinhaler technology is referenced in Allergy Partners' partnership materials. Adjacent technology partner enabling remote asthma monitoring and adherence, with potential to expand across Allergy Partners' asthma patient population.
• Asthma and Allergy Foundation of America (AAFA): National nonprofit patient advocacy organization focused on asthma and allergy education, research, and policy. Not a direct competitor but a relevant ecosystem player for patient awareness, clinical guidelines, and policy advocacy shaping Allergy Partners' operating environment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/user/MyAllergyPartners
• Facebookfacebook.com/AllergyPartners
• LinkedInlinkedin.com/company/allergypartners
• Xx.com/AllergyPartners

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Allergy Partners